Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP973761.RAkaFxT3g0f19_pff_TYUaQLGvED1HzSLZ1Ozi2NHyzEw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP973761.RAkaFxT3g0f19_pff_TYUaQLGvED1HzSLZ1Ozi2NHyzEw130_assertion type Assertion NP973761.RAkaFxT3g0f19_pff_TYUaQLGvED1HzSLZ1Ozi2NHyzEw130_head.
- NP973761.RAkaFxT3g0f19_pff_TYUaQLGvED1HzSLZ1Ozi2NHyzEw130_assertion description "[Progression was faster in patients with SCA2 mutations and normal alleles with 22 or fewer repeats (P = .02) and in patients with SCA3 mutations with parkinsonism and/or dystonia at baseline (P = .003).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973761.RAkaFxT3g0f19_pff_TYUaQLGvED1HzSLZ1Ozi2NHyzEw130_provenance.
- NP973761.RAkaFxT3g0f19_pff_TYUaQLGvED1HzSLZ1Ozi2NHyzEw130_assertion evidence source_evidence_literature NP973761.RAkaFxT3g0f19_pff_TYUaQLGvED1HzSLZ1Ozi2NHyzEw130_provenance.
- NP973761.RAkaFxT3g0f19_pff_TYUaQLGvED1HzSLZ1Ozi2NHyzEw130_assertion SIO_000772 22491195 NP973761.RAkaFxT3g0f19_pff_TYUaQLGvED1HzSLZ1Ozi2NHyzEw130_provenance.
- NP973761.RAkaFxT3g0f19_pff_TYUaQLGvED1HzSLZ1Ozi2NHyzEw130_assertion wasDerivedFrom befree-2016 NP973761.RAkaFxT3g0f19_pff_TYUaQLGvED1HzSLZ1Ozi2NHyzEw130_provenance.
- NP973761.RAkaFxT3g0f19_pff_TYUaQLGvED1HzSLZ1Ozi2NHyzEw130_assertion wasGeneratedBy ECO_0000203 NP973761.RAkaFxT3g0f19_pff_TYUaQLGvED1HzSLZ1Ozi2NHyzEw130_provenance.